EUVIMEDEUVIMED entdecken
Crossref

Apolipoprotein B as a Protective Factor Against Atopic Dermatitis: Insights Into Lipid Metabolism From a Large Prospective Cohort of 454,974 Individuals

Aiyuan Guo iD, Dawei Zhou, Lihua Gao iD

Dermatitis® · 2025

DOI: 10.1089/derm.2024.0480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatitis®, 2025. Verfasst von Aiyuan Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: From the, Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, P.R. China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Apolipoproteins B, Lipid Metabolism. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atopic dermatitis (AD) is a chronic inflammatory skin condition influenced by lipid metabolism. Apolipoprotein B (ApoB), a crucial component of lipid transport, may be linked to AD risk, but this relationship has not been extensively studied in large cohorts.

Objectives

To investigate the association between ApoB and the risk of developing AD using data from a large, prospective cohort in the UK Biobank (UKB).

Methods

The study analyzed 454,974 participants from the UKB, with ApoB measured via blood biochemistry and nuclear magnetic resonance (NMR) spectroscopy. Cox proportional hazard models were used to evaluate the relationship between ApoB and AD risk, adjusting for demographic, lifestyle, and clinical covariates. Restricted cubic spline (RCS) analysis was employed to assess potential nonlinear relationships. Sensitivity analyses included adjusting for lipid-lowering medication use, comparing apolipoprotein A (ApoA) levels, and repeating analyses with NMR-measured ApoB.

Results

Higher ApoB levels were significantly associated with a reduced risk of AD (hazard ratio for continuous ApoB: 0.74, 95% confidence interval: 0.64-0.86, P < 0.001). RCS analysis confirmed a linear inverse relationship between ApoB and AD risk (P for overall

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicApolipoproteins BLipid MetabolismHumansFemaleProspective StudiesMaleMiddle AgedAdultProtective FactorsProportional Hazards ModelsUnited KingdomMagnetic Resonance SpectroscopyRisk FactorsAgedUK Biobank

Substanzen

Apolipoproteins B

Autor:innen und Institutionen

  • From the, Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, P.R. China.
  • Medical Ozone Research Center of Central South University, Changsha, P.R. China.

ORCID-Profile: Aiyuan Guo, Lihua Gao

Zitieren

APA

Guo, A., Zhou, D., & Gao, L. (2025). Apolipoprotein B as a Protective Factor Against Atopic Dermatitis: Insights Into Lipid Metabolism From a Large Prospective Cohort of 454,974 Individuals. Dermatitis®. https://doi.org/10.1089/derm.2024.0480

Vancouver

Guo A, Zhou D, Gao L. Apolipoprotein B as a Protective Factor Against Atopic Dermatitis: Insights Into Lipid Metabolism From a Large Prospective Cohort of 454,974 Individuals. Dermatitis®. 2025. doi:10.1089/derm.2024.0480

BibTeX
@article{Guo2025,
  author = {Guo, Aiyuan and Zhou, Dawei and Gao, Lihua},
  title = {Apolipoprotein B as a Protective Factor Against Atopic Dermatitis: Insights Into Lipid Metabolism From a Large Prospective Cohort of 454,974 Individuals},
  journal = {Dermatitis®},
  year = {2025},
  doi = {10.1089/derm.2024.0480}
}
Kostenlos starten →